Showing results (1-10 of 2,488) with videos related to
Sort By:
Pageof 249
Current Pharmaceutical Design|September 17, 2009
Rho kinase: an important mediator of atherosclerosis and vascular diseaseQian Zhou, James K LiaoCirculation Journal : Official Journal of the Japanese Circulation Society|April 29, 2010
Pleiotropic effects of statins. - Basic research and clinical perspectives -Qian Zhou, James K LiaoCurrent Pharmaceutical Design|February 10, 2009
Statins and cardiovascular diseases: from cholesterol lowering to pleiotropyQian Zhou, James K LiaoTrends in Pharmacological Sciences|January 19, 2011
Rho-associated coiled-coil-forming kinases (ROCKs): potential targets for the treatment of atherosclerosis and vascular diseaseQian Zhou, Christoph Gensch, James K LiaoJournal of Muscle Research and Cell Motility|June 7, 2011
ROCK inhibition prevents fetal serum-induced alteration in structure and function of organ-cultured mesenteric arteryYang Hoon Huh, Qian Zhou, James K Liao, et al.Vascular Pharmacology|May 28, 2015
MnTBAP stimulates angiogenic functions in endothelial cells through mitofusin-1Qian Zhou, Christoph Gensch, Constanze Keller, et al.The Journal of Clinical Investigation|March 15, 2013
Linking endothelial dysfunction with endothelial cell activationJames K LiaoCirculation|March 29, 2007
Secondary prevention of stroke and transient ischemic attack: is more platelet inhibition the answer?James K LiaoCurrent Atherosclerosis Reports|November 16, 2007
Does it matter whether or not a lipid-lowering agent inhibits Rho kinase?James K LiaoPageof 249